Streetbeat News

Products Services

LULU

Deep-pocketed investors show a divided sentiment towards Lululemon Athletica (NASDAQ:LULU), with equal bullish and bearish positions in the options market. Benzinga's tracking revealed 32 significant options activities, indicating a potential price movement between $365.0 and $470.0. The company, known for its athletic apparel and accessories, is currently trading at $393.02, up 1.06%, with an RSI suggesting it may be oversold. Analysts maintain positive ratings, with an average target price of $495.2.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 3:15 pm

CSCO

Cisco and Ford Motor Company have announced the integration of the Webex app into Ford and Lincoln vehicles, offering an enhanced in-vehicle workspace experience. This collaboration allows users to join Webex meetings via audio while driving and video when parked, directly through the vehicle's infotainment system. The service is available on select vehicles, including the 2024 Lincoln Nautilus, with plans to expand to the 2025 Lincoln Aviator and 2025 Ford Explorer.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 3:02 pm

IVV

IYR

MBB

SCHH

SPY

VMBS

VNQ

VOO

XLRE

Greg McBride, CFA, predicts that interest rates, which rose quickly, will decrease gradually. He advises savers to seek high-return opportunities and borrowers to reduce high-cost debt. The real estate market is expected to remain a seller's market with high prices and limited inventory, positively impacting real estate ETFs. Mortgage ETFs may see mixed effects due to rising home prices. Legislative acts like the CHIPS and Infrastructure Acts suggest building a diversified portfolio, with large ETFs providing a stable investment strategy.

Portfolio Pulse from Surbhi Jain

March 26, 2024 | 3:01 pm

MMM

3M (NYSE:MMM) has invested in EVOLOH, a cleantech company focusing on scaling up electrolyzer manufacturing for affordable and efficient green hydrogen production. This investment is part of 3M's commitment to supporting the hydrogen economy and clean energy transition. EVOLOH's technology, which does not require precious metals or rare earth materials, aims to lower the costs of electrolyzer modules, installation, and maintenance. 3M Ventures participated in EVOLOH's $20 million Series A fundraising to help scale manufacturing capabilities. This move aligns with 3M's broader initiatives in hydrogen technology development, including high-performance catalyst technology and a joint project with HD Hyundai for hydrogen storage solutions.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 3:01 pm

TSM

Financial analysts have observed a significant bullish trend in options activity for Taiwan Semiconductor (NYSE:TSM), with 39 unusual trades indicating a mix of bullish and bearish sentiments. The majority of trades are bullish, with a focus on a price range between $70.0 and $160.0. Notable options activity includes both puts and calls with varying sentiments and expiration dates. Taiwan Semiconductor, a leading chip foundry with a 60% market share, serves top clients like Apple, AMD, and Nvidia. The company's stock is currently down by -1.03%, trading at $138.79, with an earnings announcement expected in 23 days. Analysts maintain an Outperform rating with a target price of $150.0.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 3:01 pm

VCEL

Vericel (NASDAQ:VCEL) has been analyzed by 5 analysts in the last three months, showing unanimous bullish sentiment. The average 12-month price target is $51.6, marking a 10.02% increase from the previous target. Analysts from Truist Securities and HC Wainwright & Co. have raised their price targets, reflecting positive expectations for Vericel's performance. The company, a leader in cell therapy products for sports medicine and severe burn care, shows strong financial health with notable revenue growth, high net margin, and effective debt management.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 3:00 pm

NTHI

NEONC TECHNOLOGIES HOLDINGS, INC (NASDAQ:NTHI) is set to begin trading on NASDAQ on March 27, with an IPO price range between $11.25 and $13.75 per share. The company, focusing on developing new drugs for melanoma, breast, and lung cancer, has an insider lock-up period ending on September 23, 2024.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 3:00 pm

INZY

Inozyme Pharma's shares surged following the announcement of discussions on topline data from its Phase 1/2 trials of INZ-701 for ABCC6 and ENPP1 Deficiencies.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 2:51 pm

VERI

Veritone, Inc. (NASDAQ:VERI) launched Ask Veri, a generative AI media intelligence tool for Veritone Digital Media Hub users. It enables quick extraction of insights from media archive data. Ask Veri will be available across Veritone's applications and commercially in Q2 2024. It aims to help media professionals manage and activate data efficiently, leveraging generative AI for in-depth analysis and content insights.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 2:37 pm

DNUT

MKC

PRAX

TSLA

U.S. stocks were higher on Tuesday, with Tesla Inc (TSLA) seeing a 5.8% surge amid reports of Italy's interest in electric truck production with the company. Other stocks like Krispy Kreme (DNUT), McCormick & Company (MKC), and Praxis Precision Medicines (PRAX) also saw significant gains due to various positive developments.

Portfolio Pulse from Avi Kapoor

March 26, 2024 | 2:36 pm